Autologous bone marrow derived mesenchymal stem cells - Nipro Corproration/Sapporo Medical University
Alternative Names: Autologous bone marrow-derived mesenchymal stem cells (MSCs) therapy - Nipro Corproration/Sapporo Medical University; Human (autologous) bone marrow-derived mesenchymal stem cell - Nipro Corporation/Sappro Medical University; STEMIRAC; STEMIRAC InjLatest Information Update: 02 Oct 2021
At a glance
- Originator Nipro Corporation; Sapporo Medical University
- Developer Nipro Corporation
- Class Mesenchymal stem cell therapies; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Spinal cord injuries